A Prospective, Open-Label, Single center, Phase 1 Study of SPT-2101 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere's Disease (SPT-2101 Safety in Menieres Disease Study)
Latest Information Update: 13 Jan 2023
Price :
$35 *
At a glance
- Drugs Dexamethasone (Primary) ; Anaesthetics
- Indications Meniere's disease
- Focus Adverse reactions
- Sponsors Spiral Therapeutics
- 09 Jan 2023 Status changed to active, no longer recruiting, according to a Spiral Therapeutics media release.
- 30 Jul 2021 New trial record